Editorial · 10 Dec 2025
Research articlePublished 31 Jul 2023
A Review of the Current Status of Anthrax Medical Countermeasures
DynPort Vaccine Company LLC, Frederick, Maryland, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anthrax, the disease resulting from infection with the zoonotic bacterium Bacillus anthracis, has a high potential for use as an agent of biological terrorism and warfare, and has in fact been used for both. Given its relative high mortality rate in untreated humans, effective medical treatments and prophylactics are essential. This brief review will summarize the current state of medical countermeasures (MCM) for treating individuals exposed to anthrax as well as preventing the disease from manifesting.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioterrorism & Biodefense.
Case report · 10 Dec 2025
CRISPR: Enhancing Plant Resistance for Sustainability
Editorial · 10 Dec 2025
Adaptive Global Biodefense Against Future Threats
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioterrorism & Biodefense
- SubjectImmunology & Microbiology
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Robert V House”